CancerAppy

Primary contact
Avda Ribera De Axpe, 28
48950 Erandio
Basque
Spain
+34 673453865
Avda Ribera De Axpe, 28
48950 Erandio
Basque
Spain
+34 673453865
Links
https://cancerappy.com/
https://cancerappy.com/
Funding 💰
Total €690K
Key people 🧑🤝🧑
- Luis Martin - Co-founder & CEO
- Xabier Pena - CTO
- Raquel Páez - Chief Medical Officer
- Elisa Poyatos - Chief Research Officer
- Arianna Singson - International Business Developer
Highlights ⭐
- Solving a real problem: Cancer, which is a global problem and the identification of novel therapies is an urgent need.
- Founder with tech and business background: With a career spanning more than 15 years in technology and data science, Luis Martín is an expert in creating projects from scratch and offering them to the market. A Global Executive MBA, he also co-founder of the publishing house TatemonoProject, creative studio EstudioNOTE, and NAT innovation office.
- Patents: In November 2021, together with its collaborators, CancerAppy has found a new therapeutic target for TNBCs. In January 2022, it has identified two membrane proteins that are upregulated in NSCLC and has patented their use as targets to vectorize compounds against these tumors, or as surrogates for immune activation, to select patients o explore combinations with new immune therapies. 🔗
Video ▶️
Awards & Recognitions 🏆
Last update: August 17, 2022
Disclaimer: We can not guarantee that the information on this page is 100% correct. more